Top Markets
Coin of the day
Imaging Biometrics Ltd. Imaging Biometrics Ltd.

Imaging Biometrics Ltd.

IBAI
Rangering i aksjer #41258
Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier,... Imaging Biometrics Ltd., founded in 1965 and headquartered in Saint Helier, Jersey, specializes in medical imaging diagnostics and clinical patient care. The company extends its services across the United Kingdom, Switzerland, the European Union, and the United States. Its operations are structured into three main segments: a Holding Company, Medical Software, and Oral Gallium Maltolate (GaM). The Medical Software division develops a comprehensive suite of ready-to-use software applications for the healthcare sector. This portfolio includes IB Clinic, which serves as the foundational platform for all IB software; IB Neuro, a specialized platform for MR DSC perfusion processing; and IB Delta Suite, designed to generate Delta T1 maps from routine MR examinations. Further offerings comprise IB DCE and IB Diffusion, both providing in-depth insights into blood flow and water diffusion throughout the body. For non-invasive assessments, the company provides StoneChecker and Liver Surface Nodularity, which are computed tomography (CT) processing tools that assist clinicians in evaluating kidney stones and liver health. Additional software includes IB ASL, used to measure cerebral blood flow for diagnosing conditions like stroke and dementia, and IB Zero G, an innovative technology that eliminates the need for gadolinium contrast agents in standard imaging. The suite also features IB Nimble, facilitating virtual collaboration among healthcare professionals. Beyond software, the company's Oral Gallium Maltolate (GaM) segment is actively pursuing the development of IB003, a gallium maltolate drug candidate currently in Phase 1 clinical trials for treating glioblastoma. Imaging Biometrics Ltd. also offers consulting services. The entity, which was previously known as IQ-AI Limited, is slated to adopt the name Imaging Biometrics Ltd. in May 2025.
Aksjekurs
$0.01197417
Markedsverdi
$29.54K
Endring (1 dag)
13.55%
Endring (1 år)
22.84%
Land
JE
Handel Imaging Biometrics Ltd. (IBAI)

Kategori

P/B-forhold for Imaging Biometrics Ltd. (IBAI)
P/B-forhold per September 2026 TTM: 5.94
Ifølge Imaging Biometrics Ltd. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 5.94. Ved slutten av 2023 hadde selskapet et P/B-forhold på 90.96.
P/B-historikk for Imaging Biometrics Ltd. fra 2000 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
2026 (TTM) 5.94 -41.09%
2024 10.09 -88.91%
2023 90.96 1,829.77%
2022 4.71 -45.86%
2021 8.71 -38.52%
2020 14.16 364.11%
2019 3.05 15.61%
2018 2.64 -30.60%
2017 3.80 -237.75%
2016 -2.76 -74.64%
2015 -10.89 -242.84%
2014 7.62 1,314.23%
2013 0.54 28.77%
2012 0.42 -58.11%
2011 1.00 -32.16%
2010 1.47 -6.63%
2009 1.58 3.44%
2008 1.53 -19.72%
2007 1.90 -52.96%
2006 4.04 45.33%
2005 2.78 -18.33%
2004 3.40 27.59%
2003 2.67 -12.62%
2002 3.05 7.49%
2001 2.84 -18.50%
2000 3.48 0.00%
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
2.652 -55.38%
US
25.1557 323.23%
US
38.3716 545.58%
AU
6.0644 2.03%
US
11.039 85.73%
US